跳至主要内容
欧盟官方标签名称词汇表条目 29691

UROCANIC ACID

本记录确认了用于欧盟化妆品标签标示的官方通用成分名称。它本身并不能确认该物质获准使用、不受限制或安全。

全球证据概览

所解析的身份在 13 个已索引市场数据集中的 8 个有匹配的监管证据:8 条国家记录和 0 条欧盟附件记录。下方列出每项结果和证据缺口。

8 个市场有证据
已检查的市场
13
有证据的市场
8
证据缺口
5
已解析的标识符
4

已解析的物质身份

CAS:104-98-327538-35-8
EC:203-258-4248-515-1
成分索引记录:
UROCANIC ACID
化妆品功能: UV ABSORBER

2-Propenoic acid, 3-(1H-imidazol-4-yl)-

清单限制备注: II/418

9 个匹配或报告的名称
UROCANIC ACID3-Imidazol-4-ylacrylic acid (Urocanic acid) and its ethyl ester3-Imidazol-4-ylacrylic acid and its ethyl ester3-Imidazol-4-ylacrylic acid (urocanic acid) and its ethyl ester3-Imidazol-4-ylacrylic acid and its ethyl ester (Urocanic acid)3-咪唑-4-基丙烯酸(尿刊酸)及其乙 酯 — 3-Imidazol-4-ylacrylic acid and its ethyl ester (urocanic acid) ( CAS No. 104-98-3/ CAS No. 27538-35-8)우로카닌산, 우로카닌산에칠Ácido 3-imidazol-4-ilacrílico (ácido urocânico) e seu éster etílico3-Imidazol-4-ylacrylic acid (Urocanic acid) and its ethyl ester (urocanic acid) (CAS No. 104-98-3/27538-35-8)

全部 13 个市场的监管证据

打开每条匹配记录,查看其范围、浓度、条件、警示语和官方来源版本。

滑动或横向滚动以查看数据集覆盖范围和后续操作。

市场结果记录数据集含义 / 后续操作
European Union
EU
未找到匹配项0
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review.
Great Britain
GB
Prohibited1打开记录 1
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
请查看每条关联记录及其确切条件。
Canada
CA
Prohibited1打开记录 1
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
请查看每条关联记录及其确切条件。
New Zealand
NZ
Prohibited1打开记录 1
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
请查看每条关联记录及其确切条件。
ASEAN
ASEAN
Prohibited1打开记录 1
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
请查看每条关联记录及其确切条件。
China
CN
Prohibited1打开记录 1
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
请查看每条关联记录及其确切条件。
Japan
JP
未找到匹配项0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
Prohibited1打开记录 1
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
请查看每条关联记录及其确切条件。
United States
US
未找到匹配项0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
未找到匹配项0
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Brazil
BR
Prohibited1打开记录 1
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
请查看每条关联记录及其确切条件。
India
IN
Prohibited1打开记录 1
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
请查看每条关联记录及其确切条件。
Saudi Arabia
SA
未找到匹配项0
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.
没有与此筛选条件匹配的市场行。

匹配的市场记录和条件

化学身份与性质

CAS 104-98-3 的 PubChem 二维化学结构
CAS 104-98-3PubChem CID 736715

Urocanic Acid

Urocanic acid is an alpha,beta-unsaturated monocarboxylic acid that is prop-2-enoic acid substituted by a 1H-imidazol-4-yl group at position 3. It is a metabolite of hidtidine. It has a role as a chromophore and a human metabolite. It is a member of imidazoles and an alpha,beta-unsaturated monocarboxylic acid. It is a conjugate acid of a urocanate. — ChEBI

IUPAC 名称
(E)-3-(1H-imidazol-5-yl)prop-2-enoic acid
分子式
C6H6N2O2
分子量
138.12 g/mol
精确质量
138.042927438 Da
XLogP3
0.0
拓扑极性表面积
66.0 Ų
氢键供体
2
氢键受体
3
共价单元
1
已定义的立体中心
0

又称

Urocaninic acid(2E)-3-(1H-imidazol-4-yl)prop-2-enoic acid3-(1H-Imidazol-4-yl)-2-propenoic acid2-Propenoic acid, 3-(1H-imidazol-4-yl)-G8D26XJJ3BNSC-663572-Propenoic acid, 3-(1H-imidazol-4-yl)-, (E)-CHEBI:27248
另有 16 个已报告名称
Acid, UrocanicGlyoxalinylacrylic AcidAcid, GlyoxalinylacrylicRefChem:901492203-258-43-(1H-imidazol-5-yl)prop-2-enoic acidtrans-Urocanic acid4-imidazoleacrylic acid3465-72-3urocanateimidazoleacrylic acid(E)-3-(1H-imidazol-5-yl)acrylic acid5-Imidazoleacrylic acid(2E)-3-(1H-IMIDAZOL-4-YL)ACRYLIC ACID(E)-3-(4-Imidazolyl)acrylic acid3-Imidazol-4-ylacrylic acid
外部数据库标识符

来自其他科学数据库的证据

NIH PubChem PUG-View
标识符精确匹配736715

Attributed physical-property, hazard, environmental and use annotations.

  • Cosmetic Ingredient Review Conclusion: The safety of this ingredient has not been documented and substantiated. The CIR Expert Panel cannot conclude whether Urocanic Acid is safe for use in cosmetic products until such time as the appropriate safety data have been obtained and evaluated. 来源: Cosmetic Ingredient Review (CIR)
  • Cosmetic Ingredient Review Finding(s): Ingredients for which the data are insufficient and their use in cosmetics is not supported 来源: Cosmetic Ingredient Review (CIR)

映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录

科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。

其他来源的覆盖范围和匹配状态
来源结果已检查
EMBL-EBI ChEBI需要审核2026-08-31
NIH PubChem PUG-View精确匹配2026-08-31

已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 27538-35-8 的 PubChem 二维化学结构
CAS 27538-35-8PubChem CID 6365633

Ethyl urocanate

IUPAC 名称
ethyl (E)-3-(1H-imidazol-5-yl)prop-2-enoate
分子式
C8H10N2O2
分子量
166.18 g/mol
精确质量
166.074227566 Da
XLogP3
0.7
拓扑极性表面积
55.0 Ų
氢键供体
1
氢键受体
3
共价单元
1
已定义的立体中心
0

又称

Parasonarl Mark II(E)-Urocanic acid ethyl esterUNII-GS4W88OP01GS4W88OP01EINECS 248-515-1Ethyl (E)-3-(1H-imidazol-4-yl)-2-propenoate2-Propenoic acid, 3-(1H-imidazol-4-yl)-, ethyl ester, (2E)-2-Propenoic acid, 3-(1H-imidazol-4-yl)-, ethyl ester, (E)-
另有 16 个已报告名称
2-Propenoic acid, 3-(1H-imidazol-5-yl)-, ethyl ester, (2E)-3-(1H-Imidazol-4-yl)-2-propenoic acid, ethyl ester2-Propenoic acid, 3-(1H-imidazol-4-yl)-, ethyl esterRefChem:139070ETHYL UROCANATE [INCI](e)-3-(1h-imidazol-4-yl)-2-propenoic acid ethyl esterEthyl (2E)-3-(1H-imidazol-4-yl)prop-2-enoateethyl (2E)-3-(1H-imidazol-5-yl)prop-2-enoateEthyl 3-(1H-imidazol-4-yl)acrylateHPMLGOFBKNGJAM-ONEGZZNKSA-NEthyl (E)-3-(4-Imidazolyl)acrylateAS-48227(E)-ethyl 3-(1H-imidazol-4-yl)acrylateethyl (E)-3-(1H-imidazol-5-yl)acrylateEN300-1455951Ethyl(2E)-3-(1H-imidazol-4-yl)prop-2-enoate

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

进一步查看此记录

在配方中筛查打开独立对比

官方来源与范围

导入自委员会实施决定 (EU) 2025/1175(数据集版本 EU 2025/1175)。词汇表为第 19(1)(g) 条所要求的成分表提供通用成分名称;它不是准许清单或安全清单。

打开官方决定